What's new
What changed in 2026, and what's coming
Changes that affect what you pay for medication, newest first. Each one links to its source.
Dates to know
| When | What happens |
|---|---|
| Oct 15 – Dec 7, 2026 | Medicare open enrollment. Compare drug plans for 2027 with your exact medication list. Use our checklist. |
| Jan 1, 2027 | Medicare's negotiated prices start for 15 more drugs, including Ozempic, Wegovy, Trelegy and Xtandi. |
| Jan 1 – Mar 31, 2027 | Medicare Advantage open enrollment. If you're in a Medicare Advantage plan, you can switch plans once. |
| Any time | Apply for Medicare Extra Help, drugmaker free-drug programs, and community health centers. |
Recent changes
- May 2026
TrumpRx.gov adds 600+ generic drugs
The federal cash-price site expanded about sevenfold, partnering with Cost Plus Drugs, Amazon Pharmacy and GoodRx.
Source: CNBC
- April 2026
First generic Farxiga approved
The FDA approved generic dapagliflozin, and prices have started to drop.
Source: Network Health · Our guide →
- 2026
PAN Foundation joins Patient Advocate Foundation
The two charities merged. Copay help for about 150 conditions now runs through TotalAssist.
Source: Patient Advocate Foundation
- February 2026
TrumpRx.gov launches
The federal site points cash-paying patients to drugmakers’ discounted prices. It launched with 43 drugs from five companies.
Source: CNBC
- January 2026
Medicare negotiated prices take effect for 10 drugs
Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and NovoLog now have lower Medicare prices.
Source: Medicare Rights Center
- January 2026
Part D out-of-pocket limit rises to $2,100
The yearly cap on covered Medicare drug costs went from $2,000 in 2025 to $2,100.
Source: Medicare.gov · Our guide →
- Dec 2025 – Jan 2026
Generic Januvia approved
The FDA approved generic sitagliptin from several makers. Not every pharmacy stocks it yet.
Source: Drugs.com · Our guide →
- Late 2025
15 more drugs get Medicare negotiated prices for 2027
Including Ozempic, Wegovy, Trelegy, Xtandi, Ibrance and Otezla, starting January 1, 2027.
Source: BioPharma Dive
- 2025
Cheaper versions of Xarelto, Entresto and Stelara arrive
Generic rivaroxaban and sacubitril-valsartan launched, and several Stelara biosimilars came out at large discounts.
Source: Drugs.com
Get a heads-up when prices change
One short email when a new generic, price cap or program could lower what you pay. No spam, no selling your address.